Copeptin Changes After Food Intake

The purpose of this study is to determine whether copeptin levels are affected by food intake.

Completed

Looking for future studies?

Key information

Conditions

Healthy Adults Copeptin Diabetes Insipidus Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Pituitary Diseases Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Basel

Basel, Canton of Basel-City, 4031, Switzerland

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged over 18 years

Exclusion criteria

Intake of any kind of medication (except birth control pill)
BMI >30 kg/m2
Evidence of any acute illness
History of chronic illness
Pregnancy
Known galactosemia or maltose malabsorption
Baseline glucose level >5.5 mmol/l Baseline sodium level <135 mmol/l or >145 mmol/l

Treatment and study plan

Primary outcomes

Changes in copeptin levels after intake of a oral glucose tolerance test- and a mixed meal tolerance test liquid

Time frame: 30, 60, 90, 120, 180 minutes after intake of the test liquids

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Registry information

Official study title

Copeptin During a Standardized Oral Glucose Tolerance Test and a Mixed Meal Tolerance Test

Acronym: CoMeal

Important dates

Study start: 2013
Primary completion: 2013
Study completion: 2014
First posted: Jan 21, 2013
Registry last updated: May 20, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed